Keywords: USA, GAO, Drug pricing, PhRMA, Health care reform, Competition

“Extraordinary” drug price hikes identified by USA’s GAO

Article | 12 January 2010

Print This

A study from the USA’s General Accountability Office, the investigational body of Congress, has revealed "extraordinary price increases& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in